DIY Cure? Don't Do It
Outlook|April 07, 2020
Rumours of panaceas for COVID-19 abound. But some might do more harm than good.
Ajay Sukumaran
DIY Cure? Don't Do It

After US President Trump and WhatsApp forwards endorsed the anti-malarial drug hydroxychloroquine (HCQ) to fight COVID-19, authorities and chemist associations have cautioned people against buying it—and other antiviral drugs. On March 24, the Delhi drugs control department sent out an advisory to chemists after observing that “some consumers were buying the medicines for prophylactic use”. The National Pharmaceuticals Pricing Authority of India too put out a tweet warning against self-medication. “Only by prescription, it will be sold,”

Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), told Outlook. Singhal says his association, which covers about 8.5 lakh chemists, has sent out strict instructions not to give out azithromycin, HCQ, chloroquine, lopanavir and ritonavir unless prescribed by a registered medical practitioner. “HCQ normally isn’t a medicine in high demand, but early this week there was a sudden spurt in queries,” he adds. “Rumours are creating the issue. Our doctors are doing a wonderful job and people shouldn’t panic.”

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM OUTLOOKView all
Trump's White House 'Waapsi'
Outlook

Trump's White House 'Waapsi'

Donald Trump's victory in the US presidential election may very well mean an end to democracy in the near future

time-read
6 mins  |
November 21, 2024
IMT Ghaziabad hosted its Annual Convocation Ceremony for the Class of 2024
Outlook

IMT Ghaziabad hosted its Annual Convocation Ceremony for the Class of 2024

Shri Suresh Narayanan, Chairman Managing Director of Nestlé India Limited, congratulated and motivated graduates at IMT Ghaziabad's Convocation 2024

time-read
2 mins  |
November 21, 2024
Identity and 'Infiltrators'
Outlook

Identity and 'Infiltrators'

The Jharkhand Assembly election has emerged as a high-stakes political contest, with the battle for power intensifying between key players in the state.

time-read
1 min  |
November 21, 2024
Beyond Deadlines
Outlook

Beyond Deadlines

Bibek Debroy could engage with even those who were not aligned with his politics or economics

time-read
2 mins  |
November 21, 2024
Portraying Absence
Outlook

Portraying Absence

Exhibits at a group art show in Kolkata examine existence in the absence

time-read
4 mins  |
November 21, 2024
Of Rivers, Jungles and Mountains
Outlook

Of Rivers, Jungles and Mountains

In Adivasi poetry, everything breathes, everything is alive and nothing is inferior to humans

time-read
5 mins  |
November 21, 2024
Hemant Versus Himanta
Outlook

Hemant Versus Himanta

Himanta Biswa Sarma brings his hate bandwagon to Jharkhand to rattle Hemant Soren’s tribal identity politics

time-read
5 mins  |
November 21, 2024
A Smouldering Wasteland
Outlook

A Smouldering Wasteland

As Jharkhand goes to the polls, people living in and around Jharia coalfield have just one request for the administration—a life free from smoke, fear and danger for their children

time-read
1 min  |
November 21, 2024
Search for a Narrative
Outlook

Search for a Narrative

By demanding a separate Sarna Code for the tribals, Hemant Soren has offered the larger issue of tribal identity before the voters

time-read
5 mins  |
November 21, 2024
The Historic Bonhomie
Outlook

The Historic Bonhomie

While the BJP Is trying to invoke the trope of Bangladeshi infiltrators”, the ground reality paints a different picture pertaining to the historical significance of Muslim-Adivasi camaraderie

time-read
5 mins  |
November 21, 2024